Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects - Wikidata - thesis-toulmin - TriplyDB

Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects

Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects

http://www.wikidata.org/entity/Q34271896

about

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play The clinical use of structural MRI in Alzheimer disease Voxelwise genome-wide association study (vGWAS)Cerebral atrophy in mild cognitive impairment: A systematic review with meta-analysis The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception The Alzheimer's disease neuroimaging initiative: progress report and future plans Using structural and diffusion magnetic resonance imaging to differentiate the dementias.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Data-driven regions of interest for longitudinal change in frontotemporal lobar degeneration.Bias in estimation of hippocampal atrophy using deformation-based morphometry arises from asymmetric global normalization: an illustration in ADNI 3 T MRI data.Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration.Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative.Quantitative structural MRI for early detection of Alzheimer's disease.Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals.Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes.Feature selective temporal prediction of Alzheimer's disease progression using hippocampus surface morphometry.Initial results on development and application of statistical atlas of femoral cartilage in osteoarthritis to determine sex differences in structure: data from the Osteoarthritis Initiative.Boosting power for clinical trials using classifiers based on multiple biomarkers.Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease.Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment High-Dimensional Medial Lobe Morphometry: An Automated MRI Biomarker for the New AD Diagnostic Criteria.Empowering imaging biomarkers of Alzheimer's disease Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population.Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.Methods and challenges in quantitative imaging biomarker development Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies.Tensor-based morphometry with stationary velocity field diffeomorphic registration: application to ADNI Neuroimaging measures as endophenotypes in Alzheimer's disease Nonlinear registration of longitudinal images and measurement of change in regions of interest Progression of brain atrophy in spinocerebellar ataxia type 2: a longitudinal tensor-based morphometry study.Obesity is linked with lower brain volume in 700 AD and MCI patients Evaluation of Cross-Protocol Stability of a Fully Automated Brain Multi-Atlas Parcellation Tool.Discriminant analysis of intermediate brain atrophy rates in longitudinal diagnosis of Alzheimer's disease Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease

P2860

Q24594531-5AD024C4-0621-4DCE-BC08-BFDA5864F354 Q24609648-6BE1FB00-9C5E-4DCA-8258-9BC0C58B797E Q24616471-512E1E6A-4BB0-4572-BE07-558DC8D0D8A7 Q26744866-A619A2FB-3D36-437C-8781-1229DF7CC67B Q27006831-49A7BD7A-ADF6-471D-A4B1-568E34839480 Q28749585-9A5A091B-B526-4061-B870-6CD3BD78F740 Q30836806-42E9F2AA-8F46-43F7-9950-7AAE2AD6300E Q30971403-83179D93-3316-426A-A33D-B5E53F63BA25 Q31122791-0A431393-F9EF-4485-8360-78D4D2CD3733 Q33518172-992212FE-8587-4E9F-BE42-115DC7C20DDC Q33562216-0E375BB4-BB1E-43FA-8F19-2C6BEBB3298D Q33572446-CEB93F78-DC3F-4BD4-9BAD-B444BFB2D655 Q33729033-5779B594-486F-4A31-92F6-9722174B007E Q33759240-5471F3CA-8FCB-483E-8429-C10D171D2E36 Q33798435-D965031C-DA71-47FA-B817-44CBE31F860C Q33842492-587428FB-65B6-4BFE-936D-471CA3B93A22 Q33917390-C5508D14-2C4F-4C2C-A9F5-3061449BF821 Q33938338-741A5706-F830-47F1-9777-8459FF187BEA Q33990250-D3D9D16A-E0D8-44A2-93AD-BB5B3636E49A Q33996059-DE6AA38B-D253-4ECD-9C28-22B6EBA19A05 Q33997421-08CD3E75-0697-419F-B1A0-FC644E337CE7 Q34061794-B8AD9300-EDA7-4FC9-B167-2E907192E20F Q34065449-979F7D66-CC01-4031-985B-87BEBDCF8225 Q34081087-39635057-B781-4E90-AB77-71DBB6C9F9AC Q34088600-7C1BBA52-1647-4C30-8C61-63BB43C140D6 Q34163448-76F625B8-C43B-4AE0-AE33-8AFB123B4D9D Q34181363-57917F44-F539-4A1F-8B67-74503617A426 Q34440651-DC2AD5DA-6B3A-46BF-835D-F22D121ADE6D Q34561059-DB3E501B-DB5A-40DD-BAF2-8DA55A06F552 Q34647037-CD4C343D-59D7-43F0-9021-24A5076C7D05 Q34648114-EEACAEBE-5900-4328-96DC-FDFB149CFBBD Q34715043-E6CD14DA-FD34-4A56-81CA-4DDCDBF62004 Q34746761-ED057D85-B4AA-40D9-B49F-11B16B996E6E Q34924165-5C37E549-B137-4999-9EE9-F5616899DBD0 Q35046222-2566AE8D-E8AE-4DA6-9A4F-929D37E4BED3 Q35107256-5535D344-3F57-450A-BD09-80E3B4102C67 Q35401263-725CE829-64CE-4F32-A314-62F1F7C55C0B Q35712235-F795FA1E-8DA0-4871-8993-4E55F08D2BC8 Q35834897-65865FC4-A614-4252-86C5-CD6790B4BFA9 Q36025515-A820F0C9-C869-44EF-AF6B-6179E2633AA2

P2860

Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects

http://www.wikidata.org/entity/Q34271896

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Optimizing power to track brai ...... an ADNI study of 515 subjects

@ast

Optimizing power to track brai ...... an ADNI study of 515 subjects

@en

Optimizing power to track brai ...... an ADNI study of 515 subjects

@nl

type

label

Optimizing power to track brai ...... an ADNI study of 515 subjects

@ast

Optimizing power to track brai ...... an ADNI study of 515 subjects

@en

Optimizing power to track brai ...... an ADNI study of 515 subjects

@nl

prefLabel

Optimizing power to track brai ...... an ADNI study of 515 subjects

@ast

Optimizing power to track brai ...... an ADNI study of 515 subjects

@en

Optimizing power to track brai ...... an ADNI study of 515 subjects

@nl

P1433

Q34271896-7B8E779D-0457-4029-9992-9B9A93E46C61

P1476

Q34271896-0B159A4F-5D36-4CD5-8E81-4CE78684A1D7

P2093

Q34271896-01EC553E-B5A1-44E3-805E-3FF2B5424FE1

Q34271896-023FC713-6729-484B-807C-2ECC00AD0E04

Q34271896-2CEA0C8F-9AC7-40B7-9F1D-3E9188CD12DA

Q34271896-3C8D2A50-2921-47A7-9E2F-737C4726B4CA

Q34271896-3D90EF9A-B50B-4B3E-A66C-72D30D43F863

Q34271896-5475244B-0C2B-42B3-B95B-B78A7A3A382C

Q34271896-6885A192-A843-48DB-9336-5FE152F0EC2E

Q34271896-BAE5B82B-7053-4736-A0D6-69CCD36B55B1

P2860

Q34271896-00411F9E-2C29-4AD1-8B3B-BFEDA82467EE

Q34271896-01654F44-9664-44A2-AC70-7210A57FB65E

Q34271896-04471B8B-9398-468B-95A5-09EA699A25AB

Q34271896-09781819-C93A-4769-AC64-A6183853FE45

Q34271896-0BB61F0A-B03F-4900-90BC-1FF1BAB8141F

Q34271896-0D34A29F-2F97-47BF-8D80-A45DA04D5604

Q34271896-0DA2F82E-5B40-406E-BBE1-699BB80261C2

Q34271896-0E45948F-3C1A-4FFA-B7D6-793DCD7EDB73

Q34271896-127F593E-8617-46C3-8CA0-024D7ED5D466

Q34271896-12DA9B39-B962-467A-889C-2FF1C87C1532

P304

Q34271896-83C127D5-AC99-4D93-8D01-7D8177C35F22

P31

Q34271896-90F0AF8B-6284-4D5D-AE94-882176030DCB

P356

Q34271896-7448E4BE-A710-4C6B-A8BC-EF6A16E6E0C0

P407

Q34271896-602A57E8-D20F-47DC-9F4D-CCB0C24944F9

P433

Q34271896-11A69D44-32DB-4EA8-80D1-AFFA5DE5D62D

P478

Q34271896-3F61C163-BCB9-496F-86FB-35B498E35715

P50

Q34271896-0FF971AB-9F2F-4AED-BA41-4B3079625D8B

Q34271896-3F89FFE1-D17C-4668-9775-0E8CA822DC41

Q34271896-692AD78C-700B-4B09-AA36-0E6046957B8C

Q34271896-73580C63-0045-4D3B-8E3B-1B85C2A9928B

Q34271896-87D58503-839A-4254-B618-5C03556FBEAE

Q34271896-940BD590-3B18-4631-9ABB-259F9F76B9B5

Q34271896-9B126D02-0773-4B86-82EA-1BDD6408FFC3

Q34271896-A5BE660F-93D3-4CFE-A16D-03B21B7F916E

Q34271896-CF8262EB-625F-45E5-9E7A-C35F9EB26983

Q34271896-FD681B4D-3B8B-48E9-946F-2A80A1FFCF80

P577

Q34271896-3B27681F-8EDB-4AE1-81A5-3A8D1CEDABD3

P5875

Q34271896-49385044-4362-4237-8F3D-9119AFAD0696

P698

Q34271896-E1D2FEAF-E361-413C-83C4-E95561F16177

P921

Q34271896-B7DC422C-BAA7-4B42-ACD1-80CC7A3970D4

P932

Q34271896-BCEC450E-36F7-45CC-AE11-8F048D4F5BF7

P356

J.NEUROIMAGE.2009.07.011

P1433

P1476

Optimizing power to track brai ...... an ADNI study of 515 subjects

@en

P2093

April J Ho

http://www.w3.org/2001/XMLSchema#string

Boris Gutman

http://www.w3.org/2001/XMLSchema#string

Danielle J Harvey

http://www.w3.org/2001/XMLSchema#string

Gene E Alexander

http://www.w3.org/2001/XMLSchema#string

Igor Yanovsky

http://www.w3.org/2001/XMLSchema#string

Norbert Schuff

http://www.w3.org/2001/XMLSchema#string

Suh Lee

http://www.w3.org/2001/XMLSchema#string

Yi-Yu Chou

http://www.w3.org/2001/XMLSchema#string

P2860

An Estimate of the Worldwide Prevalence and Direct Costs of Dementia in 2003

Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Voxel-based morphometry--the methods

Thresholding of statistical maps in functional neuroimaging using the false discovery rate

Nonparametric permutation tests for functional neuroimaging: a primer with examples

A voxel-based morphometric study of ageing in 465 normal adult human brains

P304

668-681

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROIMAGE.2009.07.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Paul M. Thompson

Alzheimer's Disease Neuroimaging Initiative

Matt A Bernstein

Michael W. Weiner

P577

2009-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26679303

http://www.w3.org/2001/XMLSchema#string

P698

19615450

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2971697

http://www.w3.org/2001/XMLSchema#string